Dr. Reddy's, Torrent Pharma and Laurus Synthesis all land Form 483 letters following FDA inspections
In December the FDA hit India-based Torrent Pharmaceuticals, Laurus Synthesis and Dr. Reddy’s Laboratories each with Form 483 letters published on Dec. 28. This was …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
